Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.39
-0.03 (-0.12%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pharma Stock Roundup: Novo Nordisk's New Obesity Pill Data, Roche, AstraZeneca's Pipeline Updates
March 09, 2024
This week, data from Novo Nordisk’s early-stage study on a new weight loss pill called amycretin showed that it could be more effective than Wegovy. Meanwhile, the FDA approved Johnson & Johnson's lung...
Via
Talk Markets
Exposures
Product Safety
This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO
March 08, 2024
REGENXBIO's promising gene therapy advancements! RBC Capital Markets upgraded REGENXBIO (RGNX), citing impressive RGX-202 trial results in Duchenne patients.
Via
Benzinga
3 Stock Winners That Are Up 1,000% or More in 2024
March 08, 2024
Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.
Via
InvestorPlace
9 Health Care Stocks Whale Activity In Today's Session
March 08, 2024
Via
Benzinga
Retail Traders Ditch Tesla, Apple, Google For Pharma Stocks Like Ozempic-Maker Novo Nordisk And Eli Lilly: JPMorgan
March 08, 2024
Retail traders have been observed to be selling off their shares in the 'Magnificent Seven' tech stocks, with a noticeable shift towards pharmaceutical stocks, according to a recent report by...
Via
Benzinga
Is Novavax a Buy Now?
March 04, 2024
The stock has dropped 98% over the past three years.
Via
The Motley Fool
Analyst Scoreboard: 9 Ratings For Pfizer
March 01, 2024
Via
Benzinga
3 Cancer-Fighting Biotech Stocks Showing Clinical Trial Promise
March 07, 2024
Discover the pivotal roles of cancer-fighting biotech stocks that are advancing cancer research and subsequently, their financial growth.
Via
InvestorPlace
FDA Approves Pfizer's Leukemia Drug For Kids As Old As One Year
March 07, 2024
"FDA greenlights Pfizer's inotuzumab ozogamicin (Besponsa) for pediatric CD22-positive B-cell ALL. Study: 22/53 achieved CR with 8.2 months median duration.
Via
Benzinga
Exposures
Product Safety
1 Wall Street Analyst Thinks Pfizer Stock Is Going to $45. Is It a Buy Around $26?
March 07, 2024
Betting in favor of this giant's recovery could be smart in the long term.
Via
The Motley Fool
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
March 06, 2024
Explore the ups and downs of 3 meme stocks: Imperial Petroleum, Novavax and MicroCloud, as they navigate market challenges and speculation.
Via
InvestorPlace
Injectable HIV Treatment By ViiV Healthcare Outperforms Oral Therapy, Interim Data Shows
March 06, 2024
Findings from ViiV Healthcare's LATITUDE trial on long-acting HIV treatment. Cabenuva demonstrates superior efficacy in viral load suppression compared to daily oral therapy. Key secondary endpoints...
Via
Benzinga
What's Going On With Pfizer Stock Wednesday?
March 06, 2024
Pfizer shares were trading at 11-year lows this week, but the stock climbed higher Tuesday afternoon after Ritholtz Wealth Management's Josh Brown called it the best opportunity in the market on CNBC's...
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 06, 2024
Via
Benzinga
Millionaire’s Blueprint: 7 Must-Have Stocks for Your Road to Wealthy Town
March 06, 2024
Discover must-have stocks for wealth for every investor, from healthcare and communication giants to financial and industrial sectors.
Via
InvestorPlace
The Top 3 Stocks for Beginners With Little Money in March 2024
March 05, 2024
Wager on these best stocks for beginners to buy, blending potential with security for those eager to make informed investment choices.
Via
InvestorPlace
Josh Brown Just Bought This Stock Trading At 11-Year Lows, Paying A 6.5% Dividend: 'They Always Find A Way To Rebuild'
March 05, 2024
Ritholtz Wealth Management's Josh Brown believes the best opportunity in the market right now is in a pharmaceutical stock that's trading at the same price it was at more than 10 years ago.
Via
Benzinga
Strong Buy Alert: Analysts Say to Scoop Up These 7 Stocks
March 05, 2024
The market is skyrocketing. These are seven of the best strong buy stocks that should have tremendous upside this year.
Via
InvestorPlace
Pfizer/GSK-Backed ViiV Healthcare's HIV Drug Associated With Increased Resistance, WHO Report Says
March 05, 2024
WHO's latest HIV Drug Resistance Report reveals trends in drug resistance. Discover insights on dolutegravir's impact, challenges in HIVDR monitoring, and recommendations for standardized...
Via
Benzinga
Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound
March 04, 2024
While red ink signals danger, for these oversold stocks ready for rebound, they could imply upside opportunities.
Via
InvestorPlace
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
March 04, 2024
The Biden administration wants insurers to cover preventive care, facing opposition from businesses led by Braidwood Management.
Via
Benzinga
1 S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
March 04, 2024
The picture for this stock might look bleak, but appearances can be deceiving.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
3 Magnificent Ultra-High-Yield Dividend Stocks That Are Screaming Buys in March
March 04, 2024
These high-octane income stocks, which sport a scorching-hot average yield of 8.84%, can fatten the wallets of patient investors.
Via
The Motley Fool
BridgeBio, A Top 3% Biotech, Just Snagged A $310 Million Deal; Will Shares Break Out?
March 04, 2024
BridgeBio will receive a tiered royalty on sales that begins at the low-30% range.
Via
Investor's Business Daily
Plan Ahead! 7 Stocks to Buy Before Any Market Downturn Occurs
March 03, 2024
While red ink in the broader equities space could hurt most entities, these stocks to buy for a market downturn might be resilient.
Via
InvestorPlace
3 Volatility-Busting, Low-Beta Stocks to Grab Now
March 03, 2024
These are the undervalued low-beta stocks to buy as they represent blue-chip names with robust cash flow outlook.
Via
InvestorPlace
1 Magnificent S&P 500 Dividend Stock Down 56% to Buy and Hold Forever
March 03, 2024
Investors are so worried about a one-off situation that they're looking right past the bigger bullish picture.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Hot on the Hedge Funds’ Trail: 3 Stocks Worth Your Bet?
March 02, 2024
With a 7.1% Q4 leap, hedge fund stocks underscore their role as incredible bets in a well-rounded portfolio.
Via
InvestorPlace
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
3 Overhyped Stocks Every Smart Investor Should Ignore
March 01, 2024
Learn why smart investors avoid overhyped stocks, highlighting three companies facing significant challenges in today's volatile market.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.